List of Contributors |
|
xv | |
Introduction |
|
xvii | |
1 Diversity Of Microbes In Synthesis Of Metal Nanoparticles: Progress And Limitations |
|
1 | (30) |
|
|
|
|
|
|
|
1 | (1) |
|
1.2 Synthesis of Nanoparticles by Bacteria |
|
|
2 | (7) |
|
1.3 Synthesis of Nanoparticles by Fungi |
|
|
9 | (3) |
|
1.4 Synthesis of Nanoparticles by Algae |
|
|
12 | (4) |
|
1.5 Applications of Metal Nanoparticles |
|
|
16 | (2) |
|
1.5.1 Nanoparticles as Catalyst |
|
|
16 | (1) |
|
1.5.2 Nanoparticles as Bio-membranes |
|
|
17 | (1) |
|
1.5.3 Nanoparticles in Cancer Treatment |
|
|
17 | (1) |
|
1.5.4 Nanoparticles in Drug Delivery |
|
|
17 | (1) |
|
1.5.5 Nanoparticles for Detection and Destruction of Pesticides |
|
|
17 | (1) |
|
1.5.6 Nanoparticles in Water Treatment |
|
|
18 | (1) |
|
1.6 Limitations of Synthesis of Biogenic Nanoparticles |
|
|
18 | (2) |
|
|
20 | (11) |
2 Role Of Fungi Toward Synthesis Of Nano-Oxides |
|
31 | (22) |
|
|
|
|
31 | (3) |
|
2.2 Fungus-mediated Synthesis of Nanomaterials |
|
|
34 | (12) |
|
2.2.1 Biosynthesis of Binary Nano-oxides using Chemical Precursors |
|
|
34 | (5) |
|
2.2.2 Biosynthesis of Complex Mixed-metal Nano-oxides using Chemical Precursors |
|
|
39 | (3) |
|
2.2.3 Biosynthesis of Nano-oxides using Natural Precursors Employing Bioleaching Approach |
|
|
42 | (2) |
|
2.2.4 Biosynthesis of Nano-oxides Employing Bio-milling Approach |
|
|
44 | (2) |
|
|
46 | (1) |
|
|
47 | (6) |
3 Microbial Molecular Mechanisms In Biosynthesis Of Nanoparticles |
|
53 | (30) |
|
|
Marimuthu Thiripura Sundari |
|
|
Perumal Elumalai Thirugnanam |
|
|
|
53 | (1) |
|
3.2 Chemical Synthesis of Metal Nanoparticles |
|
|
54 | (3) |
|
3.2.1 BrustSchiffrin Synthesis |
|
|
55 | (2) |
|
|
57 | (1) |
|
3.4 Biosynthesis of Nanoparticles |
|
|
58 | (3) |
|
3.5 Mechanisms for Formation or Synthesis of Nanoparticles |
|
|
61 | (8) |
|
3.5.1 Biomineralization using Magnetotactic Bacteria (MTB) |
|
|
61 | (1) |
|
3.5.2 Reduction of Tellurite using Phototroph Rhodobacter capsulatus |
|
|
62 | (1) |
|
3.5.3 Formation of AgNPs using Lactic Acid and Bacteria |
|
|
62 | (1) |
|
3.5.4 Microfluidic Cellular Bioreactor for the Generation of Nanoparticles |
|
|
62 | (3) |
|
3.5.5 Proteins and Peptides in the Synthesis of Nanoparticles |
|
|
65 | (1) |
|
3.5.6 NADH-dependent Reduction by Enzymes |
|
|
65 | (1) |
|
3.5.7 Sulfate and Sulfite Reductase |
|
|
66 | (1) |
|
|
67 | (1) |
|
3.5.9 Cysteine Desulfhydrase in Rhodopseudomonas palustris |
|
|
68 | (1) |
|
3.5.10 Nitrate and Nitrite reductase |
|
|
68 | (1) |
|
3.6 Extracellular Synthesis of Nanoparticles |
|
|
69 | (7) |
|
3.6.1 Bacterial Excretions |
|
|
69 | (2) |
|
|
71 | (1) |
|
3.6.3 Yeast: Oxido-reductase Mechanism |
|
|
72 | (1) |
|
|
73 | (3) |
|
|
76 | (2) |
|
|
78 | (5) |
4 Biofilms In Bio-Nanotechnology: Opportunities And Challenges |
|
83 | (18) |
|
|
|
|
|
83 | (1) |
|
4.2 Microbial Synthesis of Nanomaterials |
|
|
84 | (6) |
|
|
84 | (5) |
|
4.2.2 Significance of Biofilms in Biosynthesis of Nanomaterials |
|
|
89 | (1) |
|
4.2.3 Synthesis of Nanomaterials using Biofilms |
|
|
90 | (1) |
|
4.3 Interaction of Microbial Biofilms with Nanomaterials |
|
|
90 | (3) |
|
4.3.1 Nanomaterials as Anti-biofilm Agents |
|
|
90 | (2) |
|
4.3.2 Nanomaterials as a Tool in Biofilm Studies |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
94 | (7) |
5 Extremophiles And Biosynthesis Of Nanoparticles: Current And Future Perspectives |
|
101 | (22) |
|
|
|
|
|
101 | (3) |
|
5.2 Synthesis of Nanoparticles |
|
|
104 | (4) |
|
5.2.1 Microorganisms: An Asset in Nanoparticle Biosynthesis |
|
|
104 | (1) |
|
5.2.2 Extremophiles in Nanoparticle Biosynthesis |
|
|
104 | (4) |
|
5.3 Mechanism of Nanoparticle Biosynthesis |
|
|
108 | (3) |
|
5.4 Fermentative Production of Nanoparticles |
|
|
111 | (3) |
|
5.5 Nanoparticle Recovery |
|
|
114 | (1) |
|
5.6 Challenges and Future Perspectives |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
116 | (7) |
6 Biosynthesis Of Size-Controlled Metal And Metal Oxide Nanoparticles By Bacteria |
|
123 | (18) |
|
|
|
|
|
|
123 | (1) |
|
6.2 Intracellular Synthesis of Metal Nanoparticles by Bacteria |
|
|
124 | (5) |
|
6.3 Extracellular Synthesis of Metal Nanoparticles by Bacteria |
|
|
129 | (2) |
|
6.4 Synthesis of Metal Oxide and Sulfide Nanoparticles by Bacteria |
|
|
131 | (4) |
|
|
135 | (1) |
|
|
135 | (6) |
7 Methods Of Nanoparticle Biosynthesis For Medical And Commercial Applications |
|
141 | (14) |
|
|
|
|
|
141 | (3) |
|
7.2 Biosynthesis of Nanoparticles using Bacteria |
|
|
144 | (2) |
|
7.2.1 Synthesis of Silver Nanoparticles by Bacteria |
|
|
144 | (1) |
|
7.2.2 Synthesis of Gold Nanoparticles by Bacteria |
|
|
145 | (1) |
|
7.2.3 Synthesis of other Metallic Nanoparticles by Bacteria |
|
|
145 | (1) |
|
7.3 Biosynthesis of Nanoparticles using Actinomycete |
|
|
146 | (1) |
|
7.4 Biosynthesis of Nanoparticles using Fungi |
|
|
147 | (1) |
|
7.5 Biosynthesis of Nanoparticles using Plants |
|
|
148 | (1) |
|
|
149 | (1) |
|
|
149 | (6) |
8 Microbial Synthesis Of Nanoparticles: An Overview |
|
155 | (32) |
|
|
Ambarish Sharan Vidyarthi |
|
|
|
|
156 | (1) |
|
8.2 Nanoparticles Synthesis Inspired by Microorganisms |
|
|
157 | (17) |
|
8.2.1 Bacteria in NPs Synthesis |
|
|
162 | (5) |
|
8.2.2 Fungi in NPs Synthesis |
|
|
167 | (3) |
|
8.2.3 Actinomycetes in NPs Synthesis |
|
|
170 | (1) |
|
8.2.4 Yeast in NPs Synthesis |
|
|
171 | (2) |
|
8.2.5 Virus in NPs Synthesis |
|
|
173 | (1) |
|
8.3 Mechanisms of Nanoparticles Synthesis |
|
|
174 | (2) |
|
8.4 Purification and Characterization of Nanoparticles |
|
|
176 | (1) |
|
|
177 | (2) |
|
|
179 | (8) |
9 Microbial Diversity Of Nanoparticle Biosynthesis |
|
187 | (18) |
|
|
|
|
|
187 | (1) |
|
9.2 Microbial-mediated Nanoparticles |
|
|
187 | (11) |
|
|
188 | (2) |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
196 | (1) |
|
9.2.12 Microbial Quantum Dots |
|
|
196 | (1) |
|
|
197 | (1) |
|
9.2.14 Iron Sulfide-greigite |
|
|
198 | (1) |
|
9.3 Native and Engineered Microbes for Nanoparticle Synthesis |
|
|
198 | (1) |
|
9.4 Commercial Aspects of Microbial Nanoparticle Synthesis |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
200 | (5) |
10 Sustainable Synthesis Of Palladium(0) Nanocatalysts And Their Potential For Organohalogen Compounds Detoxification |
|
205 | (20) |
|
|
|
|
205 | (1) |
|
10.2 Chemically Generated Palladium Nanocatalysts for Hydrodechlorination: Current Methods and Materials |
|
|
206 | (5) |
|
|
206 | (1) |
|
|
207 | (1) |
|
10.2.3 Pd as Dehalogenation Catalyst |
|
|
207 | (1) |
|
10.2.4 Intrinsic Potential vs. Performance |
|
|
208 | (2) |
|
10.2.5 Concepts for Pd Protection |
|
|
210 | (1) |
|
10.3 Bio-supported Synthesis of Palladium Nanocatalysts |
|
|
211 | (1) |
|
|
211 | (1) |
|
10.4 Current Approaches for Synthesis of Palladium Catalysts in the Presence of Microorganisms |
|
|
212 | (5) |
|
10.4.1 Pd(II)-Tolerant Microorganisms for Future Biotechnological Approaches |
|
|
213 | (1) |
|
10.4.2 Controlling Size and Morphology during Bio-Synthesis |
|
|
214 | (1) |
|
10.4.3 Putative and Documented Mechanisms of Biosynthesis of Palladium Nanoparticles |
|
|
215 | (1) |
|
10.4.4 Isolation of Nanocatalysts from the Cell Matrix and Stabilization |
|
|
216 | (1) |
|
10.5 Bio-Palladium(0)-nanocatalyst Mediated Transformation of Organohalogen Pollutants |
|
|
217 | (1) |
|
|
218 | (1) |
|
|
219 | (6) |
11 Environmental Processing Of Zn Containing Wastes And Generation Of Nanosized Value-Added Products |
|
225 | (30) |
|
|
|
|
225 | (4) |
|
11.1.1 World Status of Zinc Production |
|
|
226 | (1) |
|
11.1.2 Environmental Impact of the Process Wastes Generated |
|
|
226 | (1) |
|
11.1.3 Production Status in India |
|
|
227 | (1) |
|
11.1.4 Recent Attempts at Processing Low-Grade Ores and Tailings |
|
|
228 | (1) |
|
11.2 Physical/Chemical/Hydrothermal Processing |
|
|
229 | (4) |
|
11.2.1 Extraction of Pb-Zn from Tailings for Utilization and Production in China |
|
|
229 | (1) |
|
11.2.2 Vegetation Program on Pb-Zn Tailings |
|
|
229 | (1) |
|
11.2.3 Recovering Valuable Metals from Tailings and Residues |
|
|
229 | (1) |
|
11.2.4 Extraction of Vanadium, Lead and Zinc from Mining Dump in Zambia |
|
|
230 | (1) |
|
11.2.5 Recovery of Zinc from Blast Furnace and other Dust/Secondary Resources |
|
|
230 | (1) |
|
11.2.6 Treatment and Recycling of Goethite Waste |
|
|
231 | (1) |
|
11.2.7 Other Hydrometallurgical Treatments of Zinc-based Industrial Wastes and Residues |
|
|
231 | (2) |
|
11.3 Biohydrometallurgical Processing: International Scenario |
|
|
233 | (5) |
|
11.3.1 Bioleaching of Zn from Copper Mining Residues by Aspergillus niger |
|
|
233 | (1) |
|
11.3.2 Bioleaching of Zinc from Steel Plant Waste using Acidithiobacillus ferrooxidans |
|
|
234 | (1) |
|
11.3.3 Bacterial Leaching of Zinc from Chat (Chert) Pile Rock and Copper from Tailings Pond Sediment |
|
|
234 | (1) |
|
11.3.4 Dissolution of Zn from Zinc Mine Tailings |
|
|
234 | (1) |
|
11.3.5 Microbial Diversity in Zinc Mines |
|
|
234 | (1) |
|
11.3.6 Chromosomal Resistance Mechanisms of A. ferrooxidans on Zinc |
|
|
235 | (1) |
|
11.3.7 Bioleaching of Zinc Sulfides by Acidithiobacillus ferrooxidans |
|
|
235 | (1) |
|
11.3.8 Bioleaching of High-Sphalerite Material |
|
|
235 | (1) |
|
11.3.9 Bioleaching of Low-Grade ZnS Concentrate and Complex Sulfides (Pb-Zn) using Thermophilic Species |
|
|
236 | (1) |
|
11.3.10 Improvement of Stains for Bio-processing of Sphalerite |
|
|
236 | (1) |
|
11.3.11 Tank Bioleaching of ZnS and Zn Polymetallic Concentrates |
|
|
237 | (1) |
|
11.3.12 Large-Scale Development for Zinc Concentrate Bioleaching |
|
|
237 | (1) |
|
11.3.13 Scale-up Studies for Bioleaching of Low-Grade Sphalerite Ore |
|
|
238 | (1) |
|
11.3.14 Zinc Resistance Mechanism in Bacteria |
|
|
238 | (1) |
|
11.4 Biohydrometallurgical Processing: Indian Scenario |
|
|
238 | (2) |
|
11.4.1 Electro-Bioleaching of Sphalerite Flotation Concentrate |
|
|
239 | (1) |
|
11.4.2 Bioleaching of Zinc Sulfide Concentrate |
|
|
239 | (1) |
|
11.4.3 Bioleaching of Moore Cake and Sphalarite Tailings |
|
|
239 | (1) |
|
11.5 Synthesis of Nanoparticles |
|
|
240 | (4) |
|
11.6 Applications of Zinc-based Value-added Products/Nanomaterials |
|
|
244 | (3) |
|
11.6.1 Hydro-Gel for Bio-applications |
|
|
244 | (1) |
|
|
244 | (1) |
|
11.6.3 Biomedical Applications |
|
|
245 | (1) |
|
11.6.4 Antibacterial Properties |
|
|
245 | (1) |
|
11.6.5 Zeolites in biomedical applications |
|
|
246 | (1) |
|
|
246 | (1) |
|
11.6.7 Prospects of Zinc Recovery from Tailings and Biosynthesis of Zinc-based Nano-materials |
|
|
246 | (1) |
|
11.7 Conclusions and Future Directions |
|
|
247 | (1) |
|
|
248 | (7) |
12 Interaction Between Nanoparticles And Plants: Increasing Evidence Of Phytotoxicity |
|
255 | (18) |
|
|
|
|
255 | (1) |
|
12.2 PlantNanoparticle Interactions |
|
|
256 | (1) |
|
12.3 Effect of Nanoparticles on Plants |
|
|
256 | (1) |
|
|
257 | (1) |
|
|
257 | (1) |
|
12.4 Mechanisms of Nanoparticle-induced Phytotoxicity |
|
|
257 | (6) |
|
|
257 | (5) |
|
12.4.2 Transfer through Ion Channels Post-ionization |
|
|
262 | (1) |
|
12.4.3 Aquaporin Mediated |
|
|
262 | (1) |
|
12.4.4 Carrier Proteins Mediated |
|
|
262 | (1) |
|
12.4.5 Via Organic Matter |
|
|
262 | (1) |
|
12.4.6 Complex Formation with Root Exudates |
|
|
262 | (1) |
|
|
263 | (1) |
|
12.5 Effect on Physiological Parameters |
|
|
263 | (3) |
|
12.5.1 Loss of Hydraulic Conductivity |
|
|
263 | (1) |
|
|
263 | (1) |
|
12.5.3 Absorption and Accumulation |
|
|
263 | (1) |
|
12.5.4 Generation of Reactive Oxygen Species (ROS) |
|
|
264 | (1) |
|
12.5.5 Biotransformation of NPs |
|
|
264 | (2) |
|
12.6 Genectic and Molecular Basis of NP Phytotoxicity |
|
|
266 | (1) |
|
12.7 Conclusions and Future Perspectives |
|
|
266 | (1) |
|
|
267 | (6) |
13 Cytotoxicology Of Nanocomposites |
|
273 | (30) |
|
|
|
273 | (1) |
|
|
274 | (7) |
|
13.2.1 Mechanisms of Cellular Toxicity |
|
|
274 | (2) |
|
13.2.2 Effect of Glutathione (GSH) in Oxidative Stress |
|
|
276 | (1) |
|
13.2.3 Damage to Cellular Biomolecules |
|
|
277 | (4) |
|
13.3 Nanoparticle Fabrication |
|
|
281 | (8) |
|
13.3.1 Physicochemical Characteristics of NPs |
|
|
282 | (2) |
|
|
284 | (3) |
|
13.3.3 Factors Affecting the Internalization of NPs |
|
|
287 | (2) |
|
13.4 Immunological Response |
|
|
289 | (3) |
|
13.4.1 Cytokine Production |
|
|
289 | (1) |
|
13.4.2 Cytotoxicity, Necrosis, Apoptosis, and Cell Death |
|
|
290 | (2) |
|
13.5 Factors to Consider to Reduce the Cytotoxic Effects of NP |
|
|
292 | (1) |
|
13.6 Conclusions and Future Directions |
|
|
293 | (1) |
|
|
294 | (9) |
14 Nanotechnology: Overview Of Regulations And Implementations |
|
303 | (28) |
|
|
|
|
303 | (2) |
|
14.2 Scope of Nanotechnology |
|
|
305 | (5) |
|
14.3 Safety Concerns Related to Nanotechnology |
|
|
310 | (1) |
|
14.4 Barriers to the Desired Regulatory Framework |
|
|
311 | (6) |
|
14.4.1 Regulatory Framework in the United States |
|
|
312 | (3) |
|
14.4.2 Global Efforts toward Regulation of Nanotechnology |
|
|
315 | (2) |
|
14.5 Biosynthesis of Microbial Bio-nanoparticles: An Alternative Production Method |
|
|
317 | (8) |
|
|
325 | (1) |
|
|
326 | (5) |
Name index |
|
331 | (2) |
Subject index |
|
333 | |